Bempedoic acid,Rosuvastatin
Esperion,Astrazeneca
['rosuvastatin']
 clear outcomes...outstanding results for ar reduction (1.6%) in cv events
and hs-crp (22%) that is a first in ascvd arr for mace with ba (1.6%) seems better compared with rosuvastatin (1.2%) in jupiter and assumes significance since the population was enriched for cad and t2d
Clinician cum Clinical Researcher... Delivering Personalized care with RWE